NCT00085111View on ClinicalTrials.gov

Bevacizumab in Treating Young Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2005

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

bevacizumab

Given IV

Trial Locations (1)

91006-3776

COG Phase I Consortium, Arcadia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00085111 - Bevacizumab in Treating Young Patients With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter